ArticlePharmaceutics2024

Assessing Protein Content and Dimer Formation in the Bevacizumab Reference Product and Biosimilar Versions Marketed in Spain.

Alexis Oliva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.